To test the hypothesis that the T-cell receptor (Tcr) "y gene encodes a natural killer (NK) cell receptor molecule, three human NK clones and fresh peripheral blood lymphocytes with NK activity from two patients with a CDI6
Introduction
Natural killer (NK) cells are a subset of lymphocytes that have been defined by their ability to recognize and kill a variety of tumor cell lines without prior sensitization . Previous studies have clearly demonstrated that NK activity is mediated by a heterogeneous population of cells which display different constellations of cell surface antigens and vary in their ability to recognize and kill specific tumor cell lines (Zarling et al. 1981 , Lanier et al. 1983 , Pawelec et al. 1982 , Lopez-Botet et al. 1983 , Hercend et al. 1983a . The majority of NK cells present in normal human peripheral blood express the E-rosette receptor CD2 as well as the more NK-specific CD16 and Leu-19 surface markers. However, most of these cells do not express the T-cell surface antigens CD3 or CD4 and display variable levels of expression of CD8. In contrast, a minority of peripheral blood cells which are capable of non-major histocompatibility complex (MHC) restricted killing display the CD3 ÷, CD4 ÷, and/or CD8 ÷ phenotype characteristic of more mature peripheral blood T lymphocytes. The majority of NK cells appear to differ from cytotoxic T lymphocytes (CTL) in that their killing does not require recognition of target cell MHC antigens . However, NK clones have been identified which are able to mediate both MHCindependent NK killing and MHC-dependent CTL activity (Kornbluth et al. 1981 , Kornbluth 1985 , David et al. 1987 .
The observed heterogeneity of NK cell surface phenotype and cytotoxic activity has raised a number of fundamental questions concerning both the lineage(s) of NK cells and the mechanisms used by these cells to recognize their tumor cell targets. Thus, it is unclear whether some or all NK cells are developmentally related to cells of the T lymphocyte lineage. In addition, the structures utilized by NK cells to recognize tumor cell antigens remain obscure. The in vitro growth of normal human NK clones (Hercend et al. 1983a , Kornbluth et al. 1981 , Dennert 1980 , Kornbluth et al. 1982 ) and the molecular cloning of the genes encoding the human T-lymphocyte receptor for antigen (Hedrick et al. 1984a , b, Saito et al. 1984a , b, Yanagi et al. 1984 , Sim et al. 1984 , Chien et al. 1984b have made possible studies which begin to address these questions.
Human helper and cytotoxic T cells recognize antigen via a heterodimeric, idiotypic T-cell receptor molecule which has been shown to be composed of acidic (o~) and basic (/3) glycoproteins each of relative mass 40000-50000 (Allison et al. 1982 , Haskins et al. 1983 , Meuer et al. 1983 ). The genes encoding both chains of the receptor have been cloned and shown to be composed of germ line variable (V), diversity (D) (at least in the case of the Tcr~ genes), joining (J), and constant (C) gene segments which undergo specific rearrangements during T-cell ontogeny to produce mature Tcr c~ and/3 genes (Hedrick et al. 1984a , b, Saito et al. 1984a , b, Yanagi et al. 1984 , Sim et al. 1984 , Chien et al. 1984a , Gascoigne et al. 1984 , Siu et al. 1984a . In addition, a third T-cell specific gene, 3", has been described which is also composed of rearranged variable, joining, and constant gene segments (Saito et al. 1984a , Hayday et al. 1985 ). The product of the human Tcr~ gene (in conjunction with a second chain termed 6) has recently been shown to be expressed on the surface of CD3--T cells from an immunodeficiency patient as well as on the surface of several T-cell tumor lines and a small subset of normal adult and fetal peripheral blood T cells (Brenner et al. 1986 , Weiss et al. 1986 , Moingeon et al. 1987 , Borst et al. 1987 . The function of the 3' gene product remains unknown, but several Tcrv expressing clones have been shown to be capable of mediating the non-MHC restricted killing of a variety of tumor cell targets (Moingeon et al. 1987 , Brenner et al. 1987 , Borst et al. 1987 . These findings have raised the possibility that the Tcr~ gene encodes an NK antigen receptor molecule.
In the studies described in this report, we have examined the rearrangement and expression of Tcr ~, /3, and 3' genes in three human NK clones which display different cell surface phenotypes, as well as in fresh peripheral blood lymphocytes (PBL) with NK activity from two patients with a CD16 ÷ lymphocytosis. The results demonstrate that NK activity is not dependent on the rearrangement and expression of the Tcr~ gene complex. In addition, they confirm previous reports of the absence of Tcr c~ and/3 gene expression in some NK cells (Ritz et al. 1985 , Yanagi et al. 1985 , Reynolds et al. 1985 , Lanier et al. 1986 ) and suggest a molecular mechanism which could explain the previously described dual NK and CTL function of certain NK clones.
Materials and methods
Isolation and characterization of human NK clones. NK clones 3.3, IS, and 37 were derived from primary mixed lymphocyte culture (MLC)-activated PBL plated in soft agarose as previously described (Kornbluth et al. 1982) . Cells were recloned twice in agarose and then expanded and maintained in medium consisting of RPMI 1640 supplemented with hydroxyethylpiperazine ethanesulfonic acid (HEPES; 25 mM), glutamine (2 mM), penicillin (100 units/ml), streptomycin (100 gg/ml), 15 % heat-inactivated pooled human serum (Bit-Bee, Boston, Massachusetts) and 15% interleukin-2 medium (Lymphocult-T, Biotest Diagnostics Corp., Fairfield, New Jersey). NK clone 3.3 was derived from the MLC responder-stimulator combination DMx, clone 1S from the combination BDx, and 37 from the MLC EJx. All of these clones have strong and exclusive NK activity (Kornbluth et al. 1982 , and Table 1 ). NK function was assessed in 4-h 51Cr-release assays (Kornbluth et al. 1982 ) using the NK sensitive target cell lines K562, MOLT-4, and HSB-2. Control target cell lines included phytohemagglutinin-activated PBL derived from the MLC responder (designated auto) and stimulator (designated stim) donors used to generate the clones. Clones were phenotyped by indirect immunofluorescence flow cytometry using the monoclonal antibodies 9.6 (anti-CD2), 64.1 (anti-CD3), 66.1 (anti-CD4), and 51.1 (anti-CD8) generously provided by Dr. John Hansen. The B73.1 (anti-CD16) monoclonal antibody was kindly provided by Dr. Giorgio Trinchieri.
Patient samples. Both of the patients in this study were seen on an outpatient basis at Rush-Presbyterian-St. Luke's Medical Center. Patient 1 is a 56-year-old, otherwise healthy and asymptomatic female suspected of having chronic lymphocytic leukemia. Her absolute white blood cell count at the time of the study was 15 600/mm 3, with 66% lymphocytes and 34% polymorphonuclear lymphocytes (PMN). Patient 2 is a 35-year-old asymptomatic male suspected of having chronic lymphocytic leukemia. At the time of the study, his absolute white blood cell count was 25400/mm 3 with 57% lymphocytes, 24% PMN, 9% monocytes, and 10% eosinophils. Peripheral blood from both patients was sterilely collected into preservative-free heparin and subjected to Ficoll gradient separation, and the mononuclear population was then divided into aliquots for direct irnmunofluorescence analysis and the preparation of DNA and RNA as described below. Cells were phenotyped by direct immunofluorescence flow cytometry on an EPICS C flow cytometer using the following monoclonal reagents: Leu-5 (anti-CD2), Leu-4 (anti-CD3), Leu-3 (anti-CD4), Leu-2 (anti-CD8), Leu-11 (anti-CD16), IL-2R (anti-CD25), Leu-7, DR (anti-HLA-DR), and Leu-19 (BectonDickinson, Mountain View, California). The surface phenotypes of the patients' cells were determined at least three times over a 3-month period, and those of both patients remained stable. Cells from patient 2 were fractionated into CD3 + and CD3-populations by indirect panning with Leu-4 and Leu-12 on a goat anti-mouse antibody-coated plastic dish (Wysocki and Sato 1978) prior to the preparation of DNA and RNA. After panning, the nonadherent cells were 99% CD3-(data not shown). NK activity of the patient's cells was determined by a standard 3-h 51Cr-release assay (Bray and Brahmi 1986 ) using the NK-sensitive target cell line K562. Cells were assayed both with and without 18 h of pretreatment with highly purified recombinant interleukin-2 (rlL-2) (Cetus, Emeryville, California) (100 units/ml).
Southern blot analysis. High relative mass DNA was prepared according to the method of Bell and co-workers (1981) except that the spooling step was replaced by ethanol precipitation at --20 °C. Southern blotting was performed on a minigel system using from 1 to 5 Ixg high relative mass DNA per lane. Alkaline blotting to Zeta Probe nylon membranes (Biorad, Richmond, California) and hybridizations were performed following the manufacturer's instructions except that 5% dextran sulfate (Oncor, Gaithersburg, Maryland) was included in some hybridizations. Probes were Tcr~, the 790 bp Xho I/Eco RI, or the 389 bp Bgl II constant region fragments from the Tcr~ eDNA 12A1 (Leiden et al. 1986a ) from the T-cell tumor line HPB-MLT, and Tcr~, the 0.8 kb Hind III/Eco RI genomic DNA fragment containing the J~l.3 gene segment ).
Northern blot analysis. Whole NK cell RNA (1-10 Ixg) was prepared from 5 x l0 s to 5 × 106 NK cells and from the human T-cell tumor cell line HPB-ALL according to the urea/LiC12 method of Auffray and Rougeon (1980) . Northern blotting was performed using a formaldehyde * Clones were assayed at effector-to-target cell ratios of 3 : 1 See Materials and methods for a description of auto and stim target cells * ND, not determined I[ CD3-specific antibody 64.1 was present as indicated throughout the cytotoxicity assays at a final ascites dilution of 1 : 500 minigel system and Biotrans nylon membranes (ICN Biochemical, Plainview, New York) according to standard techniques (Maniatis et al. 1982) . Prehybridization was for 2 h at 42 °C in 3 × standard sodium citrate (SSC), 50% formamide, 50 mM HEPES (pH 7.0), 5 × Denhardt's solution, 0.15 mg/ml denatured salmon sperm DNA, and 0.1% sodium dodecyl sulfate (SDS). 32p-labeled, nick-translated probe (2:,< 108 cpm/~tg) was added to the prehybridization mixture and hybridization was carried out for 16-20 h at 42 °C. Washing was performed for 2 × 15 min in 1 x SSC, 0.5% SDS, at room temperature followed by four 15-rain washes in 0.1 x SSC, at 55 °C. Autoradiography was performed for 1-10 days at --70 °C using Dupont intensifying screens. Probes were Tcr~, the full-length Tcr,~ cDNA from the human T-cell clone L17 (Leiden et al. 1986b ) in pUC18; Tcr~, the 12A1 Tcra cDNA from the human T-cell tumor line HPB-MLT (Leiden et al. 1986a ) in pUC18; and Tcrv, the Tcr v cDNA from the human T-cell tumor line HPB-MLT ) in pUC13.
Results
Characterization of NKcells. The three human NK clones used in these studies were derived from MLC as described above. Clone 3.3 displays the surface phenotype (CD2 ÷, CD16 +, CD3-, CD4-, CD8-) characteristic of the majority of peripheral blood NK cells (Table 1 ). In contrast, clones 1S and 37 display a surface phenotype more characteristic of mature peripheral blood T lymphocytes (CD2 +, CD3 +, CD4 ÷, CD8-) ( Table 1 ). All three clones possess NK activity as defined by their ability to kill K562 human tumor cells (Table 1) . This killing represents NK as opposed to CTL activity because all three cell lines fail to kill either their stimulator cells or cells expressing the same HLA antigens as their stimulator cells (Kornbluth et al. 1982 and Table 1 ). Moreover, neither clone 37 nor clone 3.3 killing of K562 targets is blocked by the addition of a monoclonal CD3-specific antibody (Table 1) which has been shown to block the CTL activity of a wide range of cytotoxic T-cell clones (Meuer et al. 1982) .
The peripheral blood from both patients contained a predominance of lymphocytes with a cell-surface phenotype (CD2 +, CD16 ÷, CD3-, CD4-, CD8-) similar to that of NK clone 3.3 (Table 2 ) and the majority of peripheral blood NK cells. As previously described (Pistoia et al. 1986 ), the CD16 + cells from both patients are uniformly CD3-. However, the CD16 + cells from these two patients differ in their surface expression of the Leu-7 antigen in that the majority of the CD16 + lymphocytes from patient 2 were strongly Leu-7 positive while only 19 % of the CD16 + cells from patient 1 coexpressed this antigen. Fresh peripheral blood cells from both of the patients displayed spontaneous NK activity as defined by MHC-independent cytotoxicity against the K562 target cell line (Table 3) . rlL-2 treatment increased the NK activity of cells from both of the patients.
Rearrangement of Tcr genes in the NK cells.
Southern blot analyses ofEco RI-, Hind HI-, and Bam HI-digested NKcell and control B-cell DNAs revealed that the NK clones and patient isolates can be divided into two groups based on their Tcr gene rearrangements. The CD3 + 1S and 37 clones both displayed distinct Tcr 13 (Fig. 1A ) and 3' (Fig. 1B) gene rearrangements, while the CD3-3.3 clone (Fig. 1 ) and the two patient samples ( Although the fresh patient isolates did not appear to display a clonal pattern of Tcr gene rearrangement by Southern blot analysis, it could be argued that, as is true of normal PBL, the patient samples are composed of a large number of heterogeneous clones which have undergone multiple, distinct Tcr~ gene rearrangements (which would not be detected as distinct rearranged bands in this Southern blotting system). This is unlikely for three reasons. (i) The intensities of the Hind III 3.5 kb C~l-containing bands (Fig. 2, lanes A3 and C3) are almost identical with those of the 6.7 kb Hind III bands from these samples, as well as with those of the analogous control bands (Fig. 2, lanes A4 and C4) . This pattern is quite distinct from that seen in polyclonal Tcr~ gene rearranging T-cell populations (such as normal PBL) which reveal significant decreases in the intensity of the 3.5 kb band, often accompanied by smearing in the region of the 10.0 kb germ-line Eco RI-C~I containing band (data not shown).
(ii) As shown in Figure 3 , at least patient sample 2 does not show evidence of Tcr~ RNA expression which always appears to accompany Tcr~ gene rearrangement. (iii) In all cases previously studied, Tcr~ gene rearrangement has preceded Tcr~ gene rearrangement. These 3' Fig. 1A and B. Southern blot analysis of Tcr gene rearrangements in NK clones. Clone 9 (C19) is an Epstein-Barr virus (EBV) transformed B lymphoblastoid cell line with germ line Tcr ~ and "y genes (Leiden et al. 1986 ). 3.3, 1S, and 37 are NK clones (see Table 1 ). BK is DNA isolated from the whole blood of a healthy volunteer. Three to five micrograms of DNA was digested with the appropriate restriction enzyme and loaded into each well. Size markers in kilobases are shown to the left of each set of blots. A Analysis of Tcr~ gene rearrangements in human NK clones.
The 10.5 kb Eco RI band from the 37 clone (lane A3) is reproducibly larger than the germ-line 10.0 kb Eco RI band and therefore represents a Tcr~ gene rearrangement in this clone. The 9.0 kb C~-containing Eco RI bands in the 37 and 3.3 cell lines (lanes A3 and 4) are due to a partially resistant Eco RI site near the C~2 gene segment (Furley et al. 1986 ) and therefore do not represent Tcr~ gene rearrangements. B Analysis of Tcr v gene rearrangements in human NK clones. The 5.0 kb Jr-containing Hind III band in the 3.3 lane (lane B10) does not represent a Tcr~ gene rearrangement but is due to the absence of a previously reported polymorphic Hind III site (Giuseppe et al. 1987 ) from one allele of this clone. This site is also absent from one allele of the DNA isolated from a healthy volunteer (BK; lane B9) gene rearrangements are visible even on Southern blots of polyclonal T-cell populations ). Thus, the finding that the 3.3 clone and the patient samples display a germ-line pattern of Tcr~ genes is consistent with the finding that their Tcr¢ genes also remain in a germ-line configuration.
Expression of Tcr genes in the NK cells. To determine whether the NK cells described in this report express Tcr genes, RNA from the three clones and one of the patient samples was subjected to Northern blot analyses using Tcr o~,/3, and 3' specific probes (Figs. 3 and 4) . Prior studies have shown that there are two forms of poly(A) + Tcr~ RNA: a mature 1.3 kb transcript, representing a functional V-D-JC rearrangement and a 1.0 kb transcript, representing a D-JC rearrangement which lacks V region sequences . Full-length Tcr c~ and 3' transcripts are both 1.6 kb in size (Sim et al. 1984 , Dialy- (Figs. 3 and 4) .
As seen in Figures 3 and 4 and summarized in Table  4 , the NK clones can be divided into two subsets based on their patterns of Tcr gene expression. The CD3 ÷ clones 37 and 1S express full-length Tcr o~ and/3 ( Fig.  3D and E) RNAs, while the CD3-3.3 clone and the CD3-, CD16 ÷ cells from patient 2 do not express detectable levels of full-length Tcr RNA. By loading five times more RNA and overexposing the autoradiograms, clone 3.3 can be shown to express very low levels of short Tcr /3 (1.0 kb) and 3' (1.3 kb) RNAs (data not shown). These RNA species presumably reflect low level transcription of the unrearranged Tcr genes present in this clone.
The present studies of Tcr gene rearrangement and expression in normal human NK clones and fresh PBL with NK activity from two patients with a CD16 + lymphocytosis provide information concerning both the lineage and function of human peripheral blood NK cells. First, the results demonstrate that human NK function is not dependent upon Tcrv gene rearrangement and expression. In addition, they confirm previous studies which have shown that NK activity is not dependent on Tcr oL//3 gene rearrangement and expression (Ritz et al. 1985 , Yanagi et al. 1985 , Reynolds et al. 1985 , Lanier et al. 1986 ). Thus, they suggest the existence of alternate NK receptor structures.
Furthermore, the present data, when taken together with previous reports, allow the delineation of at least four subsets of cells which are capable of mediating the non-MHC restricted killing of tumor cell targets. The first subset, which is represented in this study by the CD16 +, CD3-, CD4-, CD8-3.3 clone and both flesh patient isolates, is probably representative of the majority of peripheral blood NK cells, at least by cell-surface phenotype. This subset of NK cells does not rearrange or express any of the known Tcr genes. The finding that the CD3-3.3 clone and the CD3-cells from patient 2 do not express mature Tcr a, /3, or 3, transcripts and, therefore, presumably cannot express a mature Tcr molecule on their surfaces is in agreement with the previous observation that CD3 and Tcr cell-surface expression are tightly coupled (Weiss et al. 1984) .
The IS and 37 clones represent a second class of T cells which are capable of mediating the non-MHC restricted killing of NK targets. These clones, which display a cell-surface phenotype similar to that of mature peripheral blood T cells, rearrange their Tcr/3 and 3' genes and express full-length Tcr ~ and/3 transcripts. Therefore, they probably express functional Tcr molecules on their surface. This is in accord with the finding that both clones are CD3 + . While we cannot rule out the possibility that these cells express a Tcr ~//6 receptor in association with CD3, it is far more likely that they express a CD3 associated or//3 Tcr. All previously described Tcr 3"/6 expressing cells display the CD4-/CD8-surface phenotype and fail to coexpress full-length Tcr ~ and/3 transcripts. In contrast, both the 1S and 37 NK clones express the CD4 antigen, and both express full-length Tcr o~ and/3 transcripts. Because clone 37 killing of K562 targets is not inhibited by the addition of CD3-specific antibody, we would argue that the NK activity of this clone is not mediated by the Tcr/CD3 complex and would postulate that Tcr gene expression in this clone (and perhaps others with a similar cell-surface phenotype) may represent a coincident finding which is not related to its ability to recognize and kill NK targets. In fact, it is interesting to note that a subset of NK clones has been identified which express both NK and CTL activity (Kornbluth et al. 1981 , Kornbluth 1985 . These results could be explained if such cells utilize Tcr molecules for CTL function and a second, putative NK receptor for natural killing activity. Two additional subsets of cells have been described which both appear to be capable of mediating the non-MHC restricted killing of NK targets via cell-surface Tcr/CD3 complexes. First, several CD3+/Tcr c~//3 + NK clones have been described (Hercend et al. 1983b , David et al. 1987 . Unlike clone 37, the killing of K562 targets by these CD3 + clones is blocked by both monoclonal anti-CD3 reagents and by a monoclonal idiotype-specific antibody directed against the Tcr od/3 molecule present on the clones. Moreover, several of these clones have also been shown to mediate allo-CTL activity via their CD3/Tcr receptors (David et al. 1987 ). In addition, several Tcr 3,/6 + clones have been described which mediate non-MHC restricted cytotoxic activity which is also blocked by idiotype-specific and CD3-specific monoclonal antibodies (Moingeon et al. 1987 , Brenner et al. 1987 , Borst et al. 1987 . Whether the non-MHC restricted killing mediated by these two subsets of Tcr expressing cells represents an artifact of prolonged in vitro culture in IL-2 or alternatively is representative of their bona fide in vivo function requires further study.
